Intellia Therapeutics, Inc. (NTLA) Investor Relations Documents

Intellia Therapeutics, Inc. (NTLA) investor relations documents from the company's IR site: 2 presentations, 38 press releases; latest deck 2026-08-04. Read in-app with summaries. First-party data.

Corporate Presentation: Intellia Therapeutics is advancing in vivo CRISPR-based therapies, targeting a U.S. commercial launch for lonvoguran ziclumeran (lonvo-z) in HAE in early 2027.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-07Press releaseIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-06Press releaseIntellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
2026-08-04PresentationCorporate Presentation
2026-07-30Press releaseIntellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business
2026-07-06Press releaseIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-13Press releaseIntellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with H
2026-06-05Press releaseIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-06-01Press releaseIntellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral
2026-05-11Press releaseIntellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates
2026-05-05Press releaseIntellia Therapeutics to Participate in Upcoming Investor Conferences
2026-05-01Press releaseIntellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-04-29Press releaseRead More
2026-04-27Press releaseRead More
2026-04-27Press releaseRead More
2026-04-27Press releaseRead More
2026-04-27PresentationHAELO Topline Data Presentation – April 27, 2026
2026-04-24Press releaseRead More
2026-04-03Press releaseRead More
2026-03-06Press releaseRead More
2026-03-03Press releaseRead More
2026-03-02Press releaseRead More
2026-02-26Press releaseRead More
2026-02-24Press releaseRead More
2026-02-19Press releaseRead More
2026-02-06Press releaseRead More
2026-01-27Press releaseRead More
2026-01-07Press releaseRead More
2026-01-02Press releaseRead More
2025-12-05Press releaseRead More
2025-11-10Press releaseRead More
2025-11-08Press releaseRead More
2025-11-06Press releaseRead More
2025-10-27Press releaseRead More
2025-10-03Press releaseRead More
2025-09-25Press releaseRead More
2025-09-22Press releaseRead More
2025-09-18Press releaseRead More
2025-08-07Press releaseRead More
2025-08-01Press releaseRead More
2025-07-31Press releaseRead More

NTLA overview · NTLA earnings · NTLA financials · NTLA KPIs · NTLA documents · NTLA ownership · NTLA peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.